FDA Approves Rasonque for Advanced Pancreatic Cancer: What Patients and Families Should Know
The new once-daily pill nearly doubled median survival in a major trial. ... more
The new once-daily pill nearly doubled median survival in a major trial. ... more
Daraxonrasib is not fully approved yet, but the FDA has opened access ... more
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Connect with us